The effect of isomalto-oligosaccharides on human fecal flora was studied. Bifidobacteria and the Bacteroides fragilis group from human intestine could utilize isomalto-oligosaccharides but Escherichia coli and other bacteria could not. After the administration of isomaltooligosaccharides (13.5 g daily for 2 weeks) to healthy adult men and senile persons, the numbers of bifidobacteria in the feces increased. The consistency of feces was improved. These studies may support the usefulness of isomalto-oligosaccharides as components of new healthy foodstuffs for the improvement of the intestinal flora.
Isomaltooligosaccharides (IMO), sweeteners derived from corn-starch, selectively promote the growth of bifidobacteria in the human intestine. The metabolic fate of IMO in healthy men was investigated. The expiration rates of excess (13)CO2 and hydrogen of six men were measured while sedentary and while taking physical exercise after the (13)C-labeled IMO intakes. The breath H2 excretion kept at a constant state after IMO ingestion in the sedentary test and increased in the exercise test. The serum glucose and serum insulin increased 30 min after IMO ingestion. The (13)CO2 recoveries were 28.7% in the sedentary test and 60.9% in the exercise test. These recoveries were 70-80% compared those of maltose. These results indicated that a part of IMO was digested and the residual IMO was fermented by intestinal flora. The energy value of IMO might be about 75% of that of maltose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.